Associate Professor Naomi Allen
BSc, MSc, DPhil
Associate Professor in Epidemiology
- Clinical Trial Service Unit
Naomi Allen is an Associate Professor in Epidemiology, based in the Clinical Trial Service Unit and Epidemiological Studies Unit. She has worked predominantly on large-scale prospective studies such as EPIC and the Million Women Study and has a keen research interest in the role of diet, hormones and circulating biomarkers in cancer development. She is co-Principal Investigator of the Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group, which aims to conduct individual pooled analyses of the relationship between circulating biomarkers and prostate cancer risk from cohort studies from around the world. In 2011, she became Senior Epidemiologist for UK Biobank and helps co-ordinate record linkage of routine health-related datasets into the study.
Circulating isoflavone and lignan concentrations and prostate cancer risk: a meta-analysis of individual participant data from seven prospective studies including 2,828 cases and 5,593 controls.
Perez-Cornago A. et al, (2018), Int J Cancer, 143, 2677 - 2686
Reproductive factors, exogenous hormone use and risk of B-cell non-Hodgkin lymphoma in a cohort of women from the European Prospective Investigation into Cancer and Nutrition.
Costas L. et al, (2018), Am J Epidemiol
A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk.
Travis RC. et al, (2018), Cancer Res
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies.
Watts EL. et al, (2018), Eur Urol, 74, 585 - 594
The UK Biobank resource with deep phenotyping and genomic data
MARCHINI J. et al, (2018), Nature